⌘K

Login Start Free

Home/Filings/4/0001382963-16-000250

4//SEC Filing

RITTER PHARMACEUTICALS INC 4

Accession 0001382963-16-000250

$AIXCCIK 0001460702operating

View on SEC.gov Company Profile

Filed

Oct 24, 8:00 PM ET

Accepted

Oct 25, 9:52 PM ET

Size

5.3 KB

Accession

0001382963-16-000250

Insider Transaction Report

Form 4

Period: 2016-10-25

RITTER PHARMACEUTICALS INCRTTR

DirectorExec. Chairman, CSO

Transactions

Award
Non-qualified Stock Option (Right to Buy)
2016-10-25+140,044→ 140,044 total
Exercise: $2.60Exp: 2026-10-25→ Common Stock (140,044 underlying)

Footnotes (1)

[F1]The option vests ratably over 48 months following the public disclosure of top-line data results from the Issuer's Phase 2b/2 clinical trial.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

RITTER PHARMACEUTICALS INC

CIK 0001460702

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001460702

Filing Metadata

Form type: 4
Filed: Oct 24, 8:00 PM ET
Accepted: Oct 25, 9:52 PM ET
Size: 5.3 KB

View on SEC.gov